Physician profile
Vicente Soco Licen
NPI 1316903529
$1,616.26
in general payments reported to CMS, 2019-2025
13 companies · $69.81 in 2025
The $69.81 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $203 · 2021: $493 · 2022: $223 · 2023: $168 · 2024: $309 · 2025: $69.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $396.05 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $393.45 | 2021-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $302.64 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $107.06 | 2022-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Cranial Technologies, INC | $72.04 | 2020-2022 | |
| Phadia US INC. | $70.42 | 2020-2024 | Immunocap |
| Sanofi Pasteur INC. | $69.62 | 2019-2023 | |
| Kyowa Kirin, INC. | $67.69 | 2023-2024 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $42.86 | 2021-2022 | |
| Sobi, INC | $31.71 | 2021 | |
| Corium, LLC | $22.83 | 2023 | Azstarys |
| Seqirus USA INC | $20.59 | 2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $19.30 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicente Licen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.